Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the start of preclinical studies for its intranasal Naloxone product aimed at treating opioid overdoses. Collaborating with ...
Raanana, Israel, March 10, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...
Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...
(The Hill) – Emergent BioSolutions Inc., the maker of narcotic overdose treatment Narcan, said on Tuesday that the Food and Drug Administration (FDA) has accepted its application to grant priority ...
The kits include two Narcan nasal spray devices with instructions for the proper administration and steps to be taken in the event of an opioid overdose and will help serve Horace and Hickson. In this ...
Adapt Pharma will donate 20,000 cartons — 40,000 doses — of the company’s naloxone nasal spray Narcan to 4,726 universities across the nation to help curb the rates of opioid overdose deaths. The ...
Intranasal delivery of Naloxone presents several advantages, including ease of administration, eliminating the need for trained medical personnel, reduced risk of needlestick injuries and increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results